Clinical Trial Update: An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II [Phase 2, Phase 3]

View source ↗

Summary

An extension study of JR-141 for Mucopolysaccharidosis Type II is ongoing. The trial covers Phase 2 and Phase 3 and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Ii

Drugs mentioned

• JR-141

Snippet

Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis II | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING